Get startedLog in
    Picture of Scopus Biopharma logo

    SCPS — Scopus Biopharma News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Scopus Biopharma - Nasdaq Hearings Panel Informed Company, By Letter Dated December 15, Of Its Determination To Delist Co's Common Stock From Nasdaq

    Picture of Scopus Biopharma logoScopus Biopharma
    16/12/2022 11:21
    Dec 16 (Reuters) - Scopus Biopharma Inc  SCPS.O :
    * SCOPUS BIOPHARMA - NASDAQ HEARINGS PANEL INFORMED COMPANY,
BY
LETTER DATED DECEMBER 15, OF ITS DETERMINATION TO DELIST CO'S
COMMON STOCK FROM NASDAQ
    * SCOPUS BIOPHARMA INC - TRADING OF COMPANY'S COMMON STOCK
ON
NASDAQ WILL BE SUSPENDED EFFECTIVE AT OPEN OF TRADING ON
DECEMBER 19, 2022
    * SCOPUS BIOPHARMA INC - UPON SUSPENSION OF TRADING ON
NASDAQ,
SEES COMMON STOCK TO COMMENCE TRADING ON ONE OF MARKETS OPERATED
BY OTC MARKETS GROUP
    * SCOPUS BIOPHARMA INC - WILL COMMENCE TRADING ON ONE OF
MARKETS
OPERATED BY OTC MARKETS GROUP UNDER SYMBOL "SCPS"

Source text for Eikon: [ID:https://bit.ly/3WmkMKL]
Further company coverage:  SCPS.O 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Scopus Biopharma

    See all news